The Modern Diagnostic IPO opened with solid investor interest. By 5 PM on December 31, 2025, bids covered the issue 5.60 times over. This early response shows confidence in the healthcare diagnostics space.
Qualified Institutional Buyers took 4.01 times their share. Non-Institutional Investors led at 7.96 times. Retail investors bid 5.51 times their portion. Total bids reached 1.53 crore shares against 27.31 lakh offered.
Table of Contents
Company Roots and Growth Story
Modern Diagnostic & Research Centre began operations in 1985. It has built a reputation serving patients, hospitals, and corporates across India. The focus stays on reliable radiology and pathology services.
They offer ultrasound, colour doppler, CT scans, MRI, digital X-rays, and mammography. Heart and neuro lab tests join ECG, CBCT, OPG, PFT, plus routine blood work. Home sample collection helps those unable to visit centers.
With 21 centers, 17 labs, and 4 diagnostic outlets in 8 states, reach extends wide. This network supports steady demand as health awareness grows.
Subscription Numbers Breakdown
Day one painted a balanced picture. Institutions showed steady support through QIB bids. High net-worth players drove NII oversubscription. Retail participation kept pace.
Such spread across categories reduces typical IPO risks. The 5.60 times overall mark sets a positive tone for coming days.
Modern Diagnostic IPO GMP Update
Grey Market Premium gives an early read on trader sentiment. The Modern Diagnostic IPO GMP stood at ₹12 on December 31. Shares traded at ₹102 against the ₹90 issue price.
Live IPO GMP today reflects calm optimism. This premium hints at listing potential without wild swings.
Why This Issue Stands Out
Healthcare diagnostics benefits from rising needs. Modern Diagnostic fits with its experience and expansion plans. Funds will likely support new centers and equipment.
The company serves diverse clients steadily. Growth in smaller cities adds opportunity. Strong day one bids match this outlook.
Key Takeaways for Investors
Track subscription through final day. Balanced demand often leads to fair allotments. Healthcare offers defensive growth in portfolios.
Review prospectus for valuation details. Listing performance depends on market mood too.
Final Word on Modern Diagnostic IPO
Modern Diagnostic IPO started well with broad backing. Its established services and network position it for the diagnostics boom. Keep eyes on closing numbers. Solid pick for health sector watchers.
